- UroToday Home
- Pelvic Health & Reconstruction
The Latest Research in Overactive Bladder
Recent Abstracts
-
Mirabegron Add-on Therapy to Tamsulosin for the Treatment of Overactive Bladder in Men with Lower Urinary Tract Symptoms: A Randomized, Placebo-controlled Study (MATCH).Overactive BladderNovember 16, 2019
-
Seasonal Variation of Overactive Bladder Symptoms in Female Patients.Overactive BladderNovember 10, 2019
-
Overactive bladder symptoms in patients undergoing rigid and flexible cystoscopy.Overactive BladderNovember 10, 2019
-
Comparison of Two Different Drugs for Overactive Bladder, Solifenacin and Mirabegron: A Prospective Randomized Crossover Study.Overactive BladderNovember 3, 2019
-
Predictors of Poor Response and Adverse Events Following Botulinum Toxin A for Refractory Idiopathic Overactive Bladder (OAB).Overactive BladderNovember 3, 2019
-
Safety and Efficacy of Mirabegron: Analysis of a Large Integrated Clinical Trial Database of Patients with Overactive Bladder Receiving Mirabegron, Antimuscarinics, or Placebo.Overactive BladderOctober 27, 2019
-
Development and Validation of a Machine Learning Algorithm for Predicting Response to Anticholinergic Medications for Overactive Bladder Syndrome.Overactive BladderOctober 27, 2019
-
Multicriteria Decision Analysis Applied to the Clinical Use of Pharmacotherapy for Overactive Bladder Symptom Complex.Overactive BladderOctober 20, 2019
-
Investigation of the reasons for withdrawal from long-term treatment with mirabegron of treatment-naïve Japanese female patients with overactive bladder in the real-world clinical setting.Overactive BladderOctober 20, 2019
-
Outcomes for Intravesical Abobotulinumtoxin A (Dysport) Treatment in the Active Management of Overactive Bladder Symptoms-A Prospective Study.Overactive BladderOctober 20, 2019
Beyond the Abstracts
-
A Prospective Study to Evaluate Efficacy Using the Nuro™ Percutaneous Tibial Neuromodulation System in Drug-Naïve Patients with Overactive Bladder Syndrome - Beyond the AbstractOveractive BladderJuly 28, 2019
-
Vibegron (RVT-901/MK-4618/KRP-114V) Administered Once Daily as Monotherapy or Concomitantly with Tolterodine in Patients with an Overactive Bladder - Beyond the AbstractOveractive BladderJuly 12, 2019
-
A Comprehensive Review of Overactive Bladder Pathophysiology: On the Way to Tailored Treatment - Beyond the AbstractOveractive BladderMay 14, 2019
-
Abdominal versus Standard Placement of the Sacral Nerve Stimulator Implantable Pulse Generator - Beyond the AbstractOveractive BladderMarch 7, 2019
-
A Prospective, non-intErventional Registry Study of PatiEnts initiating a Course of drug Therapy for overactIVE bladder (PERSPECTIVE): Rationale, Design, and Methodology– Beyond the AbstractOveractive BladderJune 11, 2018
-
Association Between Coronary Artery Disease Severity and Overactive Bladder in Geriatric Patients: Beyond the AbstractOveractive BladderOctober 27, 2017
-
Use of Third Line Therapy for Overactive Bladder in a Practice with Multiple Subspecialty Providers: Beyond the AbstractOveractive BladderOctober 13, 2017
-
What is the true catheterization rate after intravesical onabotulinumtoxinA injection: Beyond the AbstractOveractive BladderAugust 23, 2017
-
Real-Time Changes in Brain Activity During Sacral Neuromodulation for Overactive Bladder: Beyond the AbstractOveractive BladderJuly 25, 2017
-
Impact of intravesical onabotulinumtoxinA on sexual function in women with OAB: Beyond the AbstractOveractive BladderJanuary 26, 2017
